Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5860 posts found.

lilly_building_with_american_flag_web

Lilly’s baricitinib/remdesivir combo lowers recovery time in hospitalised COVID-19 patients, according to new data

September 15, 2020 Manufacturing and Production, Research and Development COVID-19, Eli Lilly, pharma, remdesivir

Eli Lilly has unveiled promising new data from a study investigating the efficacy of baricitinib when combined with with Gilead’s …
News
shutter

MSD partners up with Seattle Genetics in two oncology development deals potentially worth over $4bn

September 15, 2020 Manufacturing and Production, Sales and Marketing MSD, Seattle Genetics, deal, pharma

MSD has signed two new oncology-based deals with Seattle Genetics which together could be worth up to around $4.4 billion. …
News
800px-shionogi_01

Shionogi launches Fetcroja in the UK for aerobic Gram-negative bacteria infections

September 15, 2020 Manufacturing and Production

Shionogi has announced the launch of its new antibiotic in the UK for the treatment of infections due to aerobic …
News
patrick_vallance_royal_society_cropped

UK Government’s Chief Scientific Adviser “told off” for advocating for early lockdown

September 15, 2020 Manufacturing and Production

Sir Patrick Vallance, the Chief Scientific Adviser to the UK Government, was “told off” for advocating for an early lockdown …
News
37233544_954551461372729_6659828700663513088_n_1

Avantor Clinical Services helps clinical trials stay on track

September 15, 2020 Manufacturing and Production

Biopharma and pharmaceutical companies developing treatments and vaccines have long faced operational challenges that cost time and money while draining …
News
spotlighton-aprile-cw_covid-19-and-cancer-1-img

Oncology research in the age of COVID-19

September 14, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CAR T, CAR-T, Cancer, feature, pharma

Matt Fellows investigates the new challenges facing the oncology space and explores the strategies that can carry it through the disruptive …
Feature
james_caggiano

Targazyme snaps up new CEO

September 11, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Targazyme, appointment

Experienced industry executive James Caggiano has been named as the new head of Californian biotech Targazyme, who will take up …
Appointment
steen-klysner-jpeg-1

Industry veteran Dr Steen Klysner appointed as Amarna’s new CEO

September 9, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amarna, appointments

Amarna Therapeutics has announced the appointment of a new Chief Executive Officer (CEO), hiring industry veteran Dr Steen Klysner to …
Appointment
carter_percy

FibroGen names appointment for newly created Chief Scientific Officer role

September 8, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointments, fibrogen

FibroGen has created the new role of Chief Scientific Officer and appointed Dr Percy Carter to the position, it has …
Appointment
molly_henderson

Advaxis Chief Financial Officer resigns

September 8, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Advaxis

Molly Henderson, the Chief Financial Officer and Executive Vice President of Advaxis, has announced her resignation that will take effect …
Appointment
shutterstock_512649

Takeda to sell another non-core portfolio for $260 million to Cheplapharm

September 8, 2020 Manufacturing and Production, Sales and Marketing Cheplapharm, Takeda, pharma

Takeda has revealed it has agreed to divest its non-core portfolio of prescription therapies to Cheplapharm in exchange for an …
News
sanofi_hq__boetie_hall_web

Extension study reveals Dupixent’s benefit can last up to three years in moderate-to-severe asthma

September 8, 2020 Manufacturing and Production, Research and Development Dupixent, Sanofi, asthma, pharma

New findings have been revealed from an extension study of Sanofi’s interleukin-4 (IL-4) and interleukin-13 (IL-13) inhibitor Dupixent (dupilumab) in …
News
800px-mono-embolex_by_danny_s

Mylan reaches agreement with Aspen for their European thrombosis business

September 8, 2020 Manufacturing and Production Mylan, aspen

Mylan has announced an agreement to acquire the intellectual property and commercialisation rights to Aspen’s thrombosis business for €641.9 million.  …
News
china_v

Chinese drug firm says thousands have been vaccinated for COVID-19 on an emergency use scheme

September 8, 2020 Manufacturing and Production China Vaccine, China Vaccine approval, coronavirus vaccine

Hundreds of thousands of people in China have been inoculated with two experimental vaccines on an emergency use scheme, according …
News
800px-thumbnail_1

Up to 60,000 in the UK may have suffered from “long COVID” new data suggests

September 8, 2020 Manufacturing and Production Vaccine, pandemic, vaccines

60,000 people across Britain may have been suffering from prolonged symptoms of coronavirus months after contracting the virus. This is …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026